Classification of non-tumorous skin pigmentation disorders using voting based probabilistic linear discriminant analysis

Classification of non-tumorous skin pigmentation disorders using voting based probabilistic linear discriminant analysis
复制标题

DOI:
10.1016/j.compbiomed.2018.05.026
复制
发表时间:
2018-08-01
影响因子:
7.7
通讯作者:
Lin, Zhiping
Lin, Zhiping
中科院分区:
工程技术2区
文献类型:
--
作者:
Liang, Yunfeng;Sun, Lei;Lin, Zhiping

文献摘要

被引文献

相似文献

非肿瘤性皮肤色素沉着障碍会对患者产生巨大的负面情绪影响。正确诊断这些疾病对于制定适当的治疗方法至关重要。在本文中,我们提出了一种基于概率线性判别分析(PLDA)的计算机方法来分类五种非肿瘤性皮肤色素沉着障碍(即雀斑,小痣,Hori痣,黄褐斑和太田痣)。为了解决色素沉着图像类内方差大的问题,提出了一种基于投票的PLDA (V-PLDA)方法。提出的V-PLDA方法在包含150张取自患者的真实图像的数据集上进行了测试。结果表明,与原始的PLDA方法以及几种最先进的图像分类方法相比,本文提出的V-PLDA方法的分类准确率显著提高(方差分析(ANOVA)检验中p < 0.001,准确率达到4%或更高)。据作者所知,这是第一个关注非肿瘤性皮肤色素沉着图像分类问题的研究。因此,本文可以为该课题的后续研究提供一个标杆。此外,所提出的V-PLDA方法在与皮肤色素沉着障碍相关的临床应用中表现出良好的性能。
Non-tumorous skin pigmentation disorders can have a huge negative emotional impact on patients. The correct diagnosis of these disorders is essential for proper treatments to be instituted. In this paper, we present a computerized method for classifying five non-tumorous skin pigmentation disorders (i.e., freckles, lentigines, Hori's nevus, melasma and nevus of Ota) based on probabilistic linear discriminant analysis (PLDA). To address the large within-class variance problem with pigmentation images, a voting based PLDA (V-PLDA) approach is proposed. The proposed V-PLDA method is tested on a dataset that contains 150 real-world images taken from patients. It is shown that the proposed V-PLDA method obtains significantly higher classification accuracy (4% or more with p < 0.001 in the analysis of variance (ANOVA) test) than the original PLDA method, as well as several state-of-the-art image classification methods. To the authors' best knowledge, this is the first study that focuses on the non-tumorous skin pigmentation image classification problem. Therefore, this paper could provide a benchmark for subsequent research on this topic. Additionally, the proposed V-PLDA method demonstrates promising performance in clinical applications related to skin pigmentation disorders.